| Mechanisms of aspirin resistance CN Floyd, A Ferro Pharmacology & therapeutics 141 (1), 69-78, 2014 | 228 | 2014 |
| Hypertension in adults: summary of updated NICE guidance RJ Boffa, M Constanti, CN Floyd, AS Wierzbicki Bmj 367, 2019 | 113 | 2019 |
| Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications CN Floyd, G Passacquale, A Ferro Clinical pharmacokinetics 51, 429-442, 2012 | 84 | 2012 |
| The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis CN Floyd, BH Ellis, A Ferro PLoS One 9 (7), e100239, 2014 | 59 | 2014 |
| The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis CN Floyd, A Mustafa, A Ferro PLoS One 9 (7), e101518, 2014 | 57 | 2014 |
| Antiplatelet drug resistance: Molecular insights and clinical implications CN Floyd, A Ferro Prostaglandins & other lipid mediators 120, 21-27, 2015 | 49 | 2015 |
| The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy EF Magavern, JC Kaski, RM Turner, H Drexel, A Janmohamed, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (1), 85-99, 2022 | 45 | 2022 |
| Indications for anticoagulant and antiplatelet combined therapy CN Floyd, A Ferro BMJ 359, 2017 | 39 | 2017 |
| The PlA1/A 2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta‐analysis CN Floyd, A Ferro British journal of clinical pharmacology 77 (3), 446-457, 2014 | 39 | 2014 |
| Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin‐resistant but not aspirin‐sensitive subjects CN Floyd, T Goodman, S Becker, N Chen, A Mustafa, E Schofield, ... British journal of clinical pharmacology 78 (2), 320-328, 2014 | 35 | 2014 |
| Cost-effectiveness of initiating pharmacological treatment in stage one hypertension based on 10-year cardiovascular disease risk: a Markov modeling study M Constanti, CN Floyd, M Glover, R Boffa, AS Wierzbicki, RJ McManus Hypertension 77 (2), 682-691, 2021 | 25 | 2021 |
| Options for the diagnosis of high blood pressure in primary care: a systematic review and economic model M Constanti, R Boffa, CN Floyd, AS Wierzbicki, RJ McManus, M Glover Journal of human hypertension 35 (5), 455-461, 2021 | 23 | 2021 |
| Opioids out of control CN Floyd, JB Warren British Journal of Clinical Pharmacology 84 (5), 813, 2017 | 19 | 2017 |
| Impact of therapeutic inertia on long-term blood pressure control: a Monte Carlo simulation study A Augustin, L Coutts, L Zanisi, AS Wierzbicki, F Shankar, PJ Chowienczyk, ... Hypertension 77 (4), 1350-1359, 2021 | 18 | 2021 |
| Dual antiplatelet therapy in coronary artery disease: comparison between ACC/AHA 2016 and ESC 2017 guidelines CN Floyd European Cardiology Review 15, e08, 2020 | 15 | 2020 |
| Antiplatelet therapy as a modulator of stroke aetiology: a meta‐analysis CA Rajkumar, CN Floyd, A Ferro British Journal of Clinical Pharmacology 80 (3), 331-341, 2015 | 15 | 2015 |
| Grapefruit juice enhances the systolic blood pressure‐lowering effects of dietary nitrate‐containing beetroot juice K O'Gallagher, S Borg Cardona, C Hill, A Al‐Saedi, F Shahed, CN Floyd, ... British journal of clinical pharmacology 87 (2), 577-587, 2021 | 14 | 2021 |
| Acute interaction between oral glucose (75 g as Lucozade) and inorganic nitrate: Decreased insulin clearance, but lack of blood pressure‐lowering CN Floyd, S Lidder, J Hunt, SA Omar, K McNeill, AJ Webb British journal of clinical pharmacology 85 (7), 1443-1453, 2019 | 14 | 2019 |
| Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability CN Floyd, DM Wood, PI Dargan European journal of clinical pharmacology 74, 349-356, 2018 | 13 | 2018 |
| Acute blood pressure-lowering effects of nitrogen dioxide exposure from domestic gas cooking via elevation of plasma nitrite concentration in healthy individuals CN Floyd, F Shahed, F Ukah, K McNeill, K O’Gallagher, CE Mills, ... Circulation Research 127 (6), 847-848, 2020 | 10 | 2020 |
